TEHRAN (ANA)- Researchers at Tehran University's Biochemistry and Biophysics Research Center have identified a new antimicrobial peptide as a new generation of effective antibiotics.
TEHRAN (ANA)- Researchers at the UC Riverside discovered that the sac around the lungs contains macrophages that fight flu infections by moving into the lungs, offering new insights into lung health and potential treatments that enhance the body’s immune response to combat drug-resistant infections.
TEHRAN (ANA)- Scientists at Rensselaer Polytechnic Institute have created a method to transform plastic waste into biodegradable spider silk using bacteria, providing an innovative and sustainable approach to tackling plastic pollution.
TEHRAN (ANA)- Researchers at Aston University have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs.
TEHRAN (ANA)- Iranian Vice-President for Science, Technology and Knowledge-Based Economy Rouhollah Deqani Firouzabadi said that the country’s scientists have developed the pneumococcal vaccine which inactivates 13 strains of bacteria.
TEHRAN (ANA)- A novel surgical implant developed by Washington State University researchers was able to kill 87% of the bacteria that cause staph infections in laboratory tests, while remaining strong and compatible with surrounding tissue like current implants.
TEHRAN (ANA)- Researchers at the Arctic University of Norway have found a bacteriocin that can help inhibit the growth of antibiotic-resistant bacteria.
TEHRAN (ANA)- For the first time, a team of scientists and physicians from the Institut Pasteur, Université Paris Cité, the Paris Public Hospital Network (AP-HP) and Inserm monitored the development of children infected with the bacterium Listeria monocytogenes up to the age of 5, and compared their development with that of uninfected gestational age-matched children.
TEHRAN (ANA)- Researchers at Hudson Institute of Medical Research have developed a novel computational method to understand the gut microbiome, challenging previous beliefs about Crohn’s Disease and paving the way for targeted microbial therapies.